Pricing

Log inSign up

Nivien Therapeutics

0 followers

‌

Nivien Therapeutics developed the first LATS1/2 kinase inhibitors.

Industries

Biotechnology

Headquarters

Boston, United States

Employees

1-10

Links


Org chart

Nathaniel Brooks Horwitz
CEO
Collapse
No reports!

Board & advisors

MK
Marc Kirschner
Advisor
Derrick Rossi
Advisor
Motaz Qadan
Advisor

Teams

Leadership Team

0 people · 0 jobs


Offices

  • HQ

    1 position, 0 job posts

Similar companies

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Cytiva

14 followers

PerkinElmer

11 followers

Editas Medicine

5 followers

Organogenesis

4 followers

Explore companies

Company
AboutContactTrust
Product
LearnExploreIterate
Business
PricingVerificationLicense
Enrich
LinkedIn ExtensionCRM EnrichmentDeveloper Portal
Social
© 2025 Orgio, Inc.
Terms
Privacy
Do not sell my info